The Methodist Hospital Research Institute

This study tested a combination of three treatments for an aggressive type of breast cancer that had stopped responding to standard chemotherapy. It combined chemotherapy (docetaxel), an immunotherapy drug (pembrolizumab), and a gene therapy designed to boost the immune system. T…

This early-stage study tested the safety of combining an existing immunotherapy drug (atezolizumab) with a new gene therapy (ADV/IL-12) for patients with advanced non-small cell lung cancer. The trial was for people whose cancer had continued to grow despite receiving standard fi…

This study tested if a specific set of knee-strengthening exercises (called a knee isometric program) worked better than the usual physical therapy for reducing pain in the front of the knee. A small group of adults with knee pain were randomly assigned to try one of the two exer…

This study observed children (age 17 and under) who received a standard rabies prevention shot after an animal bite or scratch. Researchers tracked any side effects for 30 days to confirm the shot's safety in kids. The study did not test a new treatment but monitored the safety o…